Protara Therapeutics, Inc. Common Stock (NASDAQ: TARA) last traded at $2.75, down 0.36% on the session. The quote above updates while this page is open; the figures below are drawn from Protara Therapeutics, Inc. Common Stock’s own filings and are restated only when a new one is published.
Protara Therapeutics, Inc. Common Stock trades on NASDAQ under the ticker TARA. Its market capitalisation is $162.22 million.
Valuation measures for Protara Therapeutics, Inc. Common Stock, derived from the latest quote and its most recent SEC filing.
| Market cap | $162.22M |
|---|---|
| Enterprise value | $159.92M |
| Price / book | 1.01 |
| Beta | 0.96 |
Trailing-twelve-month figures tagged in Protara Therapeutics, Inc. Common Stock's XBRL filings with the SEC.
| Net income (TTM) |
|---|
| -$70.02M |
| EPS (TTM) | -$1.37 |
|---|
| Return on equity | -43.40% |
|---|
| Cash | $17.08M |
|---|
Range and volume for TARA over the past 52 weeks.
| 52-week high | $7.82 |
|---|---|
| 52-week low | $2.51 |
| Volume | 570.8K |
| Average volume | 811.5K |
| Previous close | $2.76 |
Invest a chosen dollar amount in Protara Therapeutics, Inc. Common Stock with fractional shares.
Start investingCreate an account
Investing involves risk, including possible loss of principal. Nothing here is investment advice or a recommendation to buy or sell TARA.
A dash means FurlPay does not have that figure, not that it is zero. Nothing on this page is investment advice or a recommendation to buy or sell any security. Figures are provided for information only and may be delayed or restated.